Hula Therapeutics Revenue

Biotechnology Research • Philadelphia, Pennsylvania, United States • 1-10 Employees

Hula Therapeutics revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$250,000

Key Contacts at Hula Therapeutics

Steven Gelone

Founder, President & Ceo

Matt Kremer

Co-Founder

Ben Kiefel

Co-Founder

Matthew Beasley

Co-Founder

Company overview

Headquarters	Philadelphia, Pennsylvania, United States
Website	hulatx.com
Keywords	Immuno-Oncology
Founded	2022
Employees	1-10
Socials

About Hula Therapeutics

Hula Therapeutics is an immunotherapy company spinout from the lab of Dr, John Maris at Children’s Hospital of Philadelphia (CHOP). Hula is leveraging deep expertise to identify unique, functionally relevant, and essential tumor specific targets and make them accessible to precision therapeutics (e.g. cell therapy, T-cell engagers, bi-specifics, antibody drug conjugates) for the treatment of adults and children with solid cancers.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

C-Suite

Employees by Department

Hula Therapeutics has 4 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Hula Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-08-19	2	$250,000

Funding Insights

$250,000

Total funding amount

$250,000

Most recent funding amount

Number of funding rounds

Hula Therapeutics Tech Stack

Discover the technologies and tools that power Hula Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Microsoft Word

Editors

Azure

PaaS

Windows Server

Operating systems

IIS

Web servers

Microsoft ASP.NET

Web frameworks

Microsoft 365

Frequently asked questions

Hula Therapeutics is located in Philadelphia, Pennsylvania, US.

Hula Therapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Hula Therapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Hula Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Hula Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Hula Therapeutics has raised a total of $250,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Hula Therapeutics

Steven Gelone

Founder, President & Ceo

Matt Kremer

Co-Founder

Ben Kiefel

Co-Founder

Matthew Beasley

Co-Founder

4.8